Changes and tracking of mammographic density in relation to Pike's model of breast tissue aging: a UK longitudinal study

International Journal of Cancer. Journal International Du Cancer
Valerie A McCormackIsabel Dos Santos Silva

Abstract

Percent mammographic density (PMD) is a strong marker of breast cancer risk. It may be a correlate of the rate of breast tissue aging, as proposed by Pike to explain breast cancer age-incidence. We examined longitudinal changes in PMD in 645 breast screening attendees in London, UK, in which each had between 2 and 5 screens spanning 3-12 years at ages 50-65 years and compare these to Pike's model. Within-woman PMD declined during these ages, with a slowing rate of decline. Annual rates of decline were 1.4% (95% confidence interval: 1.2-1.6), 0.7% (0.6-0.9) and 0.1% (-0.2 to 0.4) at ages 50, 57 and 64. Dense area declined similarly, but the absolute magnitude of the rate of increase of nondense area was almost double that of dense area. PMD dropped by 2.4% (1.4-3.4) on menopausal transition and increased by 2.4% (1.4-3.5) with the use of hormone therapy. Higher body mass index, greater parity and being Afro-Caribbean or South Asian ethnicities were associated with lower PMD, but did not affect rate of change of PMD at these ages. Within-woman rank correlation of PMD was 0.80 for readings taken 9 years apart. Effects of menopause and parity and the lack of effect of menarche on age-specific PMD at these ages are consistent with t...Continue Reading

References

Nov 1, 1995·Journal of the National Cancer Institute·C ByrneR Haile
Mar 20, 1996·Journal of the National Cancer Institute·B Rosner, G A Colditz
Jan 22, 2000·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·C H van GilsA L Verbeek
Jan 2, 2003·Journal of the National Cancer Institute·Gail A GreendaleGiske Ursin
Apr 22, 2004·Journal of the National Cancer Institute·Jack CuzickStephen W Duffy
Jun 30, 2004·Maturitas·I den TonkelaarP A H van Noord
Oct 4, 2005·The Lancet Oncology·Norman F BoydAndrew D Paterson
Dec 20, 2005·Breast Cancer Research and Treatment·Francesmary ModugnoJane A Cauley
Apr 15, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gertraud MaskarinecLaurence N Kolonel
Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Valerie A McCormack, Isabel dos Santos Silva
Nov 9, 2006·Menopause : the Journal of the North American Menopause Society·Janet R GuthrieHenry G Burger
Nov 16, 2006·Journal of the National Cancer Institute·Tia R MilaneseDaniel W Visscher
Mar 8, 2007·Journal of the National Cancer Institute·Karla KerlikowskeUNKNOWN National Institutes of Health Breast Cancer Surveillance Consortium
May 18, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Celine M VachonThomas A Sellers
Apr 4, 2008·American Journal of Epidemiology·Linda E KelemenCeline M Vachon
May 2, 2008·Maturitas·Kate WeaverAnna Glasier
Jul 16, 2008·American Journal of Epidemiology·Valerie A McCormackIsabel dos Santos Silva
Oct 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Anne M KavanaghDallas R English
Dec 10, 2008·International Journal of Cancer. Journal International Du Cancer·Katherine W ReevesJane A Cauley

❮ Previous
Next ❯

Citations

Jul 13, 2011·Breast Cancer Research and Treatment·Virginia LopeUNKNOWN DDM Spain
Nov 5, 2011·Breast Cancer Research and Treatment·Elisabeth CoutoGiske Ursin
Mar 29, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Celine M VachonIsabel dos-Santos-Silva
Oct 11, 2013·BMC Cancer·Sophie Sell HellmannSisse Helle Njor
Feb 6, 2016·Cancer Causes & Control : CCC·Marta Cecilia BusanaIsabel dos-Santos-Silva
Aug 23, 2017·Breast Cancer Research and Treatment·Carolin C HackUwe G Pöhls

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Epidemiology
Valerie A McCormackIsabel dos Santos Silva
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Norman F BoydMartin Yaffe
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Jennifer StoneJohn L Hopper
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Lusine YaghjyanRulla M Tamimi
© 2022 Meta ULC. All rights reserved